Proposed S.B. No. 133
Session Year 2023

AN ACT CONCERNING UNANNOUNCED CLOSURES OF RETAIL PHARMACIES.

To ensure that patients are able to access prescription drugs during unannounced closures of retail pharmacies.

Other Bills with Similar Topics

  Drugs 

 

• HB05102 - AN ACT ALLOWING THE USE OF PSILOCYBIN FOR MEDICINAL AND THERAPEUTIC PURPOSES.
• HB05134 - AN ACT REQUIRING THE DEPARTMENT OF CONSUMER PROTECTION TO CONDUCT A STUDY AND SUBMIT A REPORT CONCERNING KRATOM.
• HB05435 - AN ACT CONCERNING NONLEGEND DRUG SALES IN VENDING MACHINES.
• HB05452 - AN ACT PROHIBITING HEALTH INSURANCE COMPANIES FROM REQUIRING PRIOR AUTHORIZATION AND STEP THERAPY.
• HB05735 - AN ACT CONCERNING PHARMACY CLOSURE ACTION PLANS.
• HB05762 - AN ACT CONCERNING SAFE DISPOSAL OF OPIOID PRESCRIPTIONS BY MEDICAID BENEFICIARIES.
• HB06113 - AN ACT PROHIBITING CERTAIN HEALTH CARRIERS FROM REQUIRING STEP THERAPY FOR PRESCRIPTION DRUGS PRESCRIBED TO TREAT MENTAL OR BEHAVIORAL HEALTH CONDITIONS.
• HB06116 - AN ACT CLASSIFYING THE DEALING OF ILLEGAL DRUGS THAT RESULT IN THE DEATH OF ANOTHER AS MANSLAUGHTER IN THE FIRST DEGREE.
• HB06146 - AN ACT CONCERNING THE PSYCHEDELIC-ASSISTED THERAPY PILOT PROGRAM.
• HB06255 - AN ACT AUTHORIZING THE STATE TO MANUFACTURE INSULIN.
• HB06345 - AN ACT ESTABLISHING A CREDIT AGAINST THE PERSONAL INCOME TAX FOR THE INSTALLATION OF IN-HOME SECURED STORAGE UNITS FOR FIREARMS OR MEDICATIONS.
• HB06350 - AN ACT ESTABLISHING A STATE-WIDE PRESCRIPTION DRUG STEWARDSHIP PROGRAM.
• HB06550 - AN ACT REQUIRING NOTICE OF DISCONTINUANCE OF PRESCRIPTION MEDICATION UNDER A WORKERS' COMPENSATION CLAIM.
• HB06619 - AN ACT CONCERNING PROHIBITING PAY FOR DELAY.
• HB06669 - AN ACT PROTECTING PATIENTS AND PROHIBITING UNNECESSARY HEALTH CARE COSTS.
• HB06718 - AN ACT CONCERNING THE SAFE STORAGE AND DISPOSAL OF CERTAIN PRESCRIPTION DRUGS, CANNABIS AND CANNABIS PRODUCTS.
• HB06734 - AN ACT CONCERNING THE DECRIMINALIZATION OF POSSESSION OF SMALL AMOUNTS OF PSILOCYBIN.
• HB06768 - AN ACT CONCERNING THE DEPARTMENT OF CONSUMER PROTECTION'S RECOMMENDATIONS REGARDING PRESCRIPTION DRUG REGULATION.
• HB06830 - AN ACT ESTABLISHING A PRESCRIPTION DRUG AFFORDABILITY BOARD.
• HB06831 - AN ACT CONCERNING THE OVERRIDE OF STEP THERAPY FOR CERTAIN MENTAL HEALTH CONDITIONS AND ESTABLISHING A TASK FORCE TO STUDY DATA COLLECTION EFFORTS REGARDING STEP THERAPY.
• SB00006 - AN ACT CONCERNING UTILIZATION REVIEW AND HEALTH CARE CONTRACTS, HEALTH INSURANCE COVERAGE FOR NEWBORNS AND STEP THERAPY.
• SB00010 - AN ACT PROMOTING ACCESS TO AFFORDABLE PRESCRIPTION DRUGS, HEALTH CARE COVERAGE, TRANSPARENCY IN HEALTH CARE COSTS, HOME AND COMMUNITY-BASED SUPPORT FOR VULNERABLE PERSONS AND RIGHTS REGARDING GENDER IDENTITY AND EXPRESSION.
• SB00028 - AN ACT CONCERNING STEP THERAPY, ADVERSE DETERMINATION AND UTILIZATION REVIEWS.
• SB00045 - AN ACT REQUIRING HIGH DEDUCTIBLE HEALTH PLAN DEDUCTIBLES TO CREDIT PAYMENTS MADE TO PURCHASE OUT-OF-PLAN PRESCRIPTION DRUGS.
• SB00080 - AN ACT CONCERNING THE SHORTAGE OF CERTAIN DRUGS PRESCRIBED TO TREAT TYPE II DIABETES.
• SB00088 - AN ACT PROHIBITING CERTAIN HEALTH CARRIERS FROM REQUIRING STEP THERAPY FOR PRESCRIPTION DRUGS PRESCRIBED TO TREAT BEHAVIORAL HEALTH CONDITIONS OR CHRONIC, DISABLING OR LIFE-THREATENING CONDITIONS OR DISEASES.
• SB00142 - AN ACT CONCERNING A STATE-OPERATED REINSURANCE PROGRAM AND HEALTH CARE COST GROWTH.
• SB00205 - AN ACT REQUIRING PHARMACISTS TO INFORM PATIENTS AND HEALTH CARE PROVIDERS REGARDING THE LEAST EXPENSIVE MEDICATION OPTION.
• SB00411 - AN ACT CONCERNING MEDICAID REIMBURSEMENT FOR PHARMACISTS DISPENSING BLISTER PACK MEDICATIONS.
• SB00434 - AN ACT CONCERNING A STATE-OPERATED REINSURANCE PROGRAM AND THE REGULATION OF HEALTH CARE COST GROWTH.
• SB00446 - AN ACT REQUIRING HEALTH INSURANCE COVERAGE FOR PERIOD PILLS.
• SB00545 - AN ACT CONCERNING THE ADEQUATE PRESCRIPTION OF PAIN MEDICATION FOR CANCER PATIENTS, PALLIATIVE AND NURSING HOME PATIENTS AND PATIENTS EXPERIENCING CHRONIC INTRACTABLE PAIN.
• SB00551 - AN ACT ALLOWING NATUROPATHIC PHYSICIANS TO PRESCRIBE MEDICATION.
• SB00554 - AN ACT ESTABLISHING A TASK FORCE TO STUDY ANTIBIOTIC RESISTANCE AND FUNDING BARRIERS TO THE CREATION OF NEW ANTIBIOTIC MEDICATIONS.
• SB00652 - AN ACT APPROPRIATING FUNDS TO STUDY HARMFUL ADDITIVES IN ILLEGALLY SOLD CANNABIS.
• SB00784 - AN ACT INCREASING PENALTIES FOR THE ILLEGAL SALE OF FENTANYL.
• SB00880 - AN ACT INCREASING THE PENALTY FOR MANUFACTURE, SALE OR DISTRIBUTION OF FENTANYL.
• SB00884 - AN ACT CLASSIFYING THE DEALING OF ILLEGAL DRUGS THAT LEADS TO A DEATH AS MANSLAUGHTER IN THE FIRST DEGREE.
• SB00889 - AN ACT CONCERNING THE FENTANYL CRISIS.
• SB01068 - AN ACT CONCERNING THE DEPARTMENT OF PUBLIC HEALTH'S RECOMMENDATIONS REGARDING A HUMAN IMMUNODEFICIENCY VIRUS PRE-EXPOSURE PROPHYLAXIS AND POST-EXPOSURE PROPHYLAXIS DRUG ASSISTANCE PROGRAM.
• SB01159 - AN ACT CONCERNING PHARMACY BENEFITS MANAGERS AND DRUG AFFORDABILITY AND TRANSPARENCY.
• SB01202 - AN ACT CONCERNING PRESCRIPTION DRUG AFFORDABILITY.
• SB01203 - AN ACT CONCERNING MEDICAL DEBT.

  Pharmacies 

 

• HB05735 - AN ACT CONCERNING PHARMACY CLOSURE ACTION PLANS.
• HB06350 - AN ACT ESTABLISHING A STATE-WIDE PRESCRIPTION DRUG STEWARDSHIP PROGRAM.
• HB06768 - AN ACT CONCERNING THE DEPARTMENT OF CONSUMER PROTECTION'S RECOMMENDATIONS REGARDING PRESCRIPTION DRUG REGULATION.
• SB01102 - AN ACT CONCERNING PHARMACIES AND PHARMACISTS.